JAK inhibitors are a class of small-molecule targeted therapies that block the activity of one or more Janus kinase (JAK) enzymes involved in intracellular signaling. They are used to treat autoimmune diseases, inflammatory disorders, hematologic malignancies, and graft-versus-host disease (GVHD) by reducing excessive immune system activity. The following is a list of JAK inhibitor APIs.
Filters
Modal title
Thank you
Thank you for sending us request for the quotation. We will get back to you asap. Thank you
Thank you
Thank you for contacting us. We will get back to you asap. Thank you
Thank you
Thank you for request submission to join as consultant. We will get back to you asap. Thank you
Thank you
Thank you for request submission to become a supplier. We will get back to you asap. Thank you
Thank you
Thank you for enquiry. We will get back to you asap. Thank you
